Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$8.51 - $13.6 $3 Million - $4.79 Million
-352,358 Reduced 53.6%
305,042 $3.2 Million
Q2 2022

Aug 15, 2022

SELL
$7.31 - $11.85 $8.61 Million - $14 Million
-1,177,785 Reduced 64.18%
657,400 $6.36 Million
Q1 2022

May 16, 2022

SELL
$7.35 - $10.63 $10.6 Million - $15.3 Million
-1,443,051 Reduced 44.02%
1,835,185 $15.1 Million
Q4 2021

Feb 14, 2022

SELL
$4.19 - $9.56 $6.75 Million - $15.4 Million
-1,611,713 Reduced 32.96%
3,278,236 $31.3 Million
Q3 2021

Nov 15, 2021

BUY
$3.56 - $4.64 $267,000 - $348,000
75,000 Added 1.56%
4,889,949 $22.7 Million
Q2 2021

Aug 16, 2021

BUY
$3.95 - $5.41 $8.53 Million - $11.7 Million
2,160,588 Added 81.4%
4,814,949 $20.8 Million
Q1 2021

May 17, 2021

BUY
$4.52 - $7.8 $12 Million - $20.7 Million
2,654,361 New
2,654,361 $14 Million
Q4 2020

Feb 16, 2021

SELL
$4.37 - $9.46 $5.28 Million - $11.4 Million
-1,208,800 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.56 - $26.93 $4.79 Million - $15.1 Million
559,749 Added 86.24%
1,208,800 $11 Million
Q2 2020

Aug 14, 2020

BUY
$21.21 - $31.55 $13.3 Million - $19.8 Million
627,182 Added 2867.9%
649,051 $17.8 Million
Q1 2020

May 15, 2020

SELL
$18.43 - $38.04 $2.37 Million - $4.9 Million
-128,764 Reduced 85.48%
21,869 $481,000
Q4 2019

Feb 14, 2020

SELL
$29.6 - $43.71 $3.88 Million - $5.73 Million
-131,091 Reduced 46.53%
150,633 $5.69 Million
Q3 2019

Nov 15, 2019

BUY
$29.87 - $42.22 $6.36 Million - $8.99 Million
213,024 Added 310.08%
281,724 $8.7 Million
Q2 2019

Aug 14, 2019

SELL
$31.16 - $39.46 $1.49 Million - $1.88 Million
-47,660 Reduced 40.96%
68,700 $2.71 Million
Q1 2019

May 15, 2019

SELL
$19.96 - $38.62 $3.67 Million - $7.09 Million
-183,640 Reduced 61.21%
116,360 $4.49 Million
Q4 2018

Feb 14, 2019

BUY
$23.57 - $32.33 $7.07 Million - $9.7 Million
300,000 New
300,000 $7.07 Million

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.